Understanding Pyrazinamide Discontinuation in Tuberculosis Treatment

Standard TB Regimen (Drug-Susceptible)

Intensive phase (2 months): Isoniazid (H) + Rifampin (R) + Pyrazinamide (Z) + Ethambutol (E) – HRZE.

Continuation phase (4 months): HR only (total 6 months).

Why Pyrazinamide (PZA) Is Stopped at 2 Months

1. Hepatotoxicity (Primary Reason)

• PZA is the most hepatotoxic first-line drug.
• Risk increases with duration, age, alcohol, viral hepatitis, malnutrition, concomitant hepatotoxic drugs.
• Limiting to 2 months balances sterilizing benefit vs. liver injury.
• ALT monitoring: baseline, 2, 4, 8 weeks; more often if risk factors.

2. Hyperuricemia & Gout

• PZA inhibits renal urate excretion (URAT1 transporter) → ↑ serum uric acid.
• Can precipitate acute gout flares; asymptomatic hyperuricemia common.
• Usually resolves after stopping.

3. Sterilizing Effect Is Front-Loaded

• PZA kills semi-dormant bacilli in acidic macrophage phagolysosomes.
• Maximal sterilizing activity in first 2 months.
• Continuing adds toxicity without proportional benefit.

4. Cost & Pill Burden

• PZA adds cost and pills; resource-limited settings benefit from shorter regimen.

5. Resistance & Interactions

• Monotherapy selects resistance; stopping reduces selection pressure if adherence falters.
• Interactions: allopurinol (↑ toxicity), antacids (↓ absorption).

Exceptions / Variations

• MDR-TB regimens: PZA often continued longer (9–12+ months) as core drug.
• TB meningitis / bone/joint TB: Extended intensive phase (3–4 months) sometimes used.
• PZA resistance: If DST shows resistance, omit entirely.
• Severe hepatotoxicity: Stop immediately; substitute (e.g., levofloxacin, linezolid).

Monitoring During PZA Phase

• LFTs (ALT, AST, bilirubin) at baseline, 2, 4, 8 weeks.
• Uric acid if gout history.
• Symptom review: nausea, vomiting, RUQ pain, dark urine, jaundice.

Patient Counseling

• Take with food (reduces GI upset).
• Avoid alcohol.
• Report yellow eyes/skin, dark urine, joint pain.
• Complete full course—stopping early breeds resistance.

Bottom Line

PZA is a potent sterilizing drug limited to 2 months primarily due to hepatotoxicity and hyperuricemia. Its early intensive use maximizes cure while minimizing chronic toxicity. Adherence to the full 6-month regimen is critical.